Vaxcyte, Inc. (PCVX)
NASDAQ·Healthcare·Biotechnology
$56.04
-5.05%
Mkt Cap $8.51B
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$89.00
Range $89.00 – $89.00
Implied Upside
+58.8%
Consensus $89.00 vs current $56.04
NASDAQ·Healthcare·Biotechnology
$56.04
-5.05%
Mkt Cap $8.51B
No recent rating data.
Price Target (15 analysts)
$89.00
Range $89.00 – $89.00
+58.8%
Consensus $89.00 vs current $56.04